Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 3 | |
Outperform | 5 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 6 analysts offering 12 month price targets for Mineralys Therapeutics Inc have a median target of 31.00, with a high estimate of 45.00 and a low estimate of 26.00. The median estimate represents a 131.69% increase from the last price of 13.38.
High | 236.3% | 45.00 |
Med | 131.7% | 31.00 |
Low | 94.3% | 26.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 17, 2025.
Average growth rate | -19.12% |
Average growth rate | +65.51% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
Average growth rate | 0.00% |
More ▼